2024-11-13 - Analysis Report
## Danaher Corp (DHR) Stock Analysis Report

**1. Performance Analysis:**

Danaher Corp (DHR) is a global science and technology company that designs, manufactures, and markets a wide range of products and services.

**Comparison to S&P 500 (VOO):**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) | Cumulative Return (DHR) | Cumulative Return (VOO) | Difference |
|------------|------|------|-------|------|-------|--------------------------|--------------------------|-----------|
| 2015-2017  | 126.5% | 12.0% | 88.1% | 0.8 | 59.4 | 350.44                | 179.55                 | 170.89    |

**Analysis:**

* DHR has consistently outperformed the S&P 500 (VOO) over the past few years.
* The current cumulative return difference of 170.89, places DHR's performance at the 42.37 percentile of its historical performance range, demonstrating strong relative performance.
* DHR has a higher CAGR and lower MDD than VOO, indicating higher potential returns and lower risk.
* Alpha analysis shows that DHR has outperformed the market (VOO) consistently, suggesting strong management and effective business strategies.
* Beta is slightly lower than 1, suggesting that DHR is less volatile than the overall market.

**2. Recent Price Action:**

* Closing Price: 239.44 (Last-market: 239.35)
* 5-day Moving Average: 244.39
* 20-day Moving Average: 251.94
* 60-day Moving Average: 264.49

**Analysis:**

* DHR is currently trading below its 5, 20, and 60-day moving averages, indicating a potential downtrend.
* The recent price action shows a decrease in price, possibly a result of a recent market sell-off.

**3. Technical Indicators:**

* RSI: 25.08
* PPO: -0.16
* 20-day Delta_Previous_Relative_Divergence: -17.1 (-)
* Expected_Return (S&P 500 vs. DHR): 131.03%

**Analysis:**

* RSI is in the oversold territory, suggesting that DHR could be ripe for a potential bounce.
* PPO is negative, indicating a potential downtrend.
* The 20-day relative divergence is also negative, indicating a short-term downward trend.
* The high expected return suggests that DHR could potentially outperform the S&P 500 over the long term.

**4. Recent Earnings and Outlook:**

| Date        | EPS | Revenue |
|-------------|-----|---------|
| 2024-10-22 | 1.13 | 5.80 B$ |
| 2024-07-23 | 1.23 | 5.74 B$ |
| 2024-04-23 | 1.47 | 5.80 B$ |
| 2024-02-21 | 1.46 | 6.41 B$ |
| 2023-10-24 | 1.53 | 5.62 B$ |

**Analysis:**

* The latest earnings report showed that DHR exceeded analysts' expectations for both EPS and revenue.
* Revenue has remained consistently high, indicating a strong underlying business performance.
* Continued expansion and growth in key segments like life sciences and diagnostics are driving this performance.

**5. Financial Information:**

**1) Revenue and Profitability:**

| Quarter      | Revenue | Profit Margin |
|--------------|---------|---------------|
| 2024-09-30  | $5.80B  | 58.66%        |
| 2024-06-30  | $5.74B  | 59.69%        |
| 2024-03-31  | $5.80B  | 60.16%        |
| 2023-12-31  | $2.69B  | 60.27%        |
| 2023-09-30  | $5.62B  | 58.23%        |

**2) Capital and Profitability:**

| Quarter      | Equity   | ROE |
|--------------|---------|-----|
| 2024-09-30  | $51.30B | 1.59% |
| 2024-06-30  | $49.90B | 1.82% |
| 2024-03-31  | $53.44B | 2.04% |
| 2023-12-31  | $53.49B | 2.02% |
| 2023-09-30  | $52.41B | 2.15% |

**Analysis:**

* DHR consistently maintains a high profit margin, indicating strong operational efficiency and effective cost control.
* ROE has remained relatively stable, indicating a healthy balance between profitability and investment.
* The company's strong financial position allows for continued investments in growth opportunities and innovation.

**6. News and Recent Issues:**

* **Earnings Release:** DHR exceeded analyst expectations for Q3 2024 earnings, demonstrating continued strong performance and growth.
* **Recent Market Outlook:** Analyst opinions are generally positive, with most analysts holding "Buy" or "Strong Buy" ratings on DHR.
* **Performance Highlights:** DHR has a long history of strong financial performance and consistent growth. 
* **Market Sentiment:**  Despite recent market volatility, investors remain optimistic about DHR's long-term growth potential.

**7. Conclusion:**

Danaher Corp (DHR) is a strong and stable company with a long history of outperforming the market. The recent earnings report and positive market sentiment further reinforce its solid fundamentals. While short-term price action may show a potential downtrend, DHR's strong financial performance and growth prospects make it a compelling investment opportunity for investors looking for long-term value. The high expected return and potential for outperformance compared to the S&P 500 makes DHR a potentially attractive addition to any diversified portfolio. 
